BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 14, 2022
View Archived Issues
Teixobactin attenuates anthrax infection in a rabbit model
Read More
Loss-of-function mutations in ZFHX3 cause intellectual disability
Read More
Astrocyte-specific IL-2 delivery shows neuroprotective effect in four neuroinflammation models
Read More
Beijing Increase Innovation Drug Research divulges SGLT2 inhibitors
Read More
Roche discloses new HBV antivirals
Read More
Qilu Regor Therapeutics presents new STING antagonists
Read More
Fochon Pharmaceuticals identifies new BTK inhibitors
Read More
DA-1726 shows efficacy in diet-induced NASH mouse model
Read More
Chinese researchers disclose cardiac myosin inhibitors
Read More
Novel neurodevelopmental disorder associated with germline variants in FBXW7
Read More
Omadacycline, a promising treatment approach for chlamydial infections
Read More
NXP-900 shows tumor growth inhibition and survival benefit in mouse model of group 4 medulloblastoma
Read More
Alpha Cognition announces discovery of GEM combinations ALPHA-0702 and ALPHA-0802
Read More
Discovery of novel cathepsin C inhibitor with anti-inflammatory activity in vivo
Read More
Evotec and Janssen Pharmaceutica establish drug discovery collaboration
Read More
Hamlet and Neurochase partner to develop novel technology to deliver Alpha-1H for CNS tumors
Read More
EHA 2022 presentations describe sickle cell disease headway and headwinds
Read More
